Physician profile
Lin Chen
NPI 1285168070
$13,718.88
in general payments reported to CMS, 2019-2025
37 companies · $5,265 in 2025
The $5,265 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,844 · 2022: $930 · 2023: $1,421 · 2024: $4,258 · 2025: $5,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,944.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $1,684.00 | 2024-2025 | Afx2 Bifurcated Endograft System, Torus Stent Graft System, Endocross Device |
| Cardiovascular Systems INC. | $1,649.18 | 2021-2023 | Diamondback Peripheral |
| Shockwave Medical, INC | $1,500.13 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $1,407.62 | 2025 | Limflow System, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inari Medical, INC. | $1,334.87 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Limflow System |
| Cagent Vascular INC | $1,050.40 | 2024-2025 | Serrantor |
| Cvrx, INC. | $791.60 | 2021-2025 | Barostim Neo System |
| Boston Scientific Corporation | $789.61 | 2021-2025 | Enroute Transcarotid Neuroprotection System, General - Angiography, Ekosonic |
| Silk Road Medical, INC. | $513.23 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abbott Laboratories | $512.23 | 2023-2024 | Diamondback Peripheral, Cardiomems, Jeti All In One Non-Sterile Kit |
| Medtronic, INC. | $288.32 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $267.44 | 2021-2025 | |
| Imperative Care, INC | $239.44 | 2025 | Symphony Catheter |
| Reflow Medical INC | $236.39 | 2025 | |
| Philips North America LLC | $188.38 | 2023-2025 | IV Other, (Dd3) Venous Stent Und |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Limflow INC. | $182.35 | 2023 | Limflow System |
| Astrazeneca Pharmaceuticals LP | $127.96 | 2021-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.34 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $103.92 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $101.64 | 2023-2024 | Xarelto |
| Pfizer INC. | $99.92 | 2021-2025 | |
| Baxter Healthcare | $77.89 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $59.45 | 2022-2025 | Verquvo |
| Amgen INC. | $57.91 | 2021-2023 | Repatha |
| Regeneron Healthcare Solutions, INC. | $46.94 | 2022-2024 | Libtayo |
| Angiodynamics, INC. | $42.89 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Atricure, INC. | $40.59 | 2024 | |
| Irhythm Technologies, INC. | $39.71 | 2023 | Zio Xt Patch |
| Novo Nordisk INC | $31.63 | 2023 | Ozempic, Rybelsus |
| Qol Medical, LLC | $23.92 | 2025 | Sucraid |
| Surmodics, INC. | $21.33 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Seagen INC. | $20.14 | 2022 | |
| Edwards Lifesciences Corporation | $19.25 | 2022 | |
| Bridgebio Pharma, INC. | $19.00 | 2025 | Attruby |
| Cardinal Health 200 LLC | $16.97 | 2021 | |
| United Therapeutics Corporation | $13.76 | 2024 | Orenitram, Remodulin |
| E.R. Squibb & Sons, L.L.C. | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lin Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.